| Date |
Title |
Category |
|
| 29/02/2012 | Forest Laboratories reports positive schizophrenia data for cariprazine | Pharmaceutical Company Product News | Read More |
| 29/02/2012 | Sanofi and Institut Pasteur create new awards scheme | Pharmaceutical Company Product News | Read More |
| 29/02/2012 | Janssen's Zytiga recommended for Welsh prostate cancer patients | Pharmaceutical Company Product News | Read More |
| 28/02/2012 | Forest Laboratories' Colobreathe launch welcomed by charity | Pharmaceutical Company Product News | Read More |
| 28/02/2012 | Novartis receives EU approval for new Glivec indication | Pharmaceutical Company Product News | Read More |
| 27/02/2012 | Janssen launches new hepatitis C support scheme | Pharmaceutical Company Product News | Read More |
| 27/02/2012 | Takeda's peginesatide accepted for review by EMA | Pharmaceutical Company Product News | Read More |
| 24/02/2012 | Hospira becomes Generic Pharmaceutical Association member | Pharmaceutical Company Product News | Read More |
| 24/02/2012 | Sanofi and Genzyme's MS drug accepted for European review | Pharmaceutical Company Product News | Read More |
| 24/02/2012 | Forest Laboratories receives EMA approval for Colobreathe | Pharmaceutical Company Product News | Read More |
| 23/02/2012 | Novartis and Enanta Pharmaceuticals agree HCV collaboration | Pharmaceutical Company Product News | Read More |
| 23/02/2012 | Shire's Lexington site receives EMA backing for Vpriv production | Pharmaceutical Company Product News | Read More |
| 22/02/2012 | Boehringer Ingelheim and Xencor announce new collaboration | Pharmaceutical Company Product News | Read More |
| 22/02/2012 | Bayer HealthCare reports positive phase III data for VEGF Trap-Eye | Pharmaceutical Company Product News | Read More |
| 22/02/2012 | AstraZeneca receives approval for thyroid cancer drug Caprelsa | Pharmaceutical Company Product News | Read More |
| 22/02/2012 | UCB commences new Cimzia study for rheumatoid arthritis | Pharmaceutical Company Product News | Read More |
| 21/02/2012 | Takeda announces positive phase III data for ulcerative colitis drug | Pharmaceutical Company Product News | Read More |
| 21/02/2012 | Novartis to revise Rasilez labelling on CHMP guidance | Pharmaceutical Company Product News | Read More |
| 21/02/2012 | Lilly receives CHMP backing for Byetta plus basal insulin | Pharmaceutical Company Product News | Read More |
| 20/02/2012 | GlaxoSmithKline receives CHMP backing for Nimenrix | Pharmaceutical Company Product News | Read More |
